We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$1B
AUM Growth
+$163M
Cap. Flow
+$128M
Cap. Flow %
12.83%
Top 10 Hldgs %
45.25%
Holding
220
New
64
Increased
24
Reduced
33
Closed
63

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$53.3M
2
OXY icon
Occidental Petroleum
OXY
+$42.5M
3
CVE icon
Cenovus Energy
CVE
+$22.7M
4
ACI icon
Albertsons Companies
ACI
+$21.1M
5
HES
Hess
HES
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 14.3%
2 Energy 12.26%
3 Communication Services 11.71%
4 Real Estate 4.34%
5 Consumer Discretionary 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPP
126
Hudson Pacific Properties
HPP
$794M
$258K 0.03%
7,704
-40,426
-84% -$1.45M
NRXP icon
127
NRX Pharmaceuticals
NRXP
$155M
$241K 0.02%
+142,525
New +$287K
GWAV icon
128
Greenwave Technology Solutions
GWAV
$2.08M
$239K 0.02%
5,079
-6,104
-55% -$569K
ENSC icon
129
Ensysce Biosciences
ENSC
$4.02M
$236K 0.02%
+65,568
New +$398K
BFRGW icon
130
Bullfrog AI Holdings Warrants
BFRGW
$155K
$232K 0.02%
80,750
ONFOW icon
131
Onfolio Holdings Warrant
ONFOW
$71.4K
$216K 0.02%
200,000
TOVX icon
132
Theriva Biologics
TOVX
$9.78M
$192K 0.02%
+139,046
New +$678K
UOKA
133
DELISTED
MDJM Ltd
UOKA
$182K 0.02%
+349
New +$329K
USAS
134
Americas Gold and Silver
USAS
$1.37B
$157K 0.02%
201,760
HEPA
135
DELISTED
Hepion Pharmaceuticals
HEPA
$128K 0.01%
+4,637
New +$184K
RVSNW icon
136
Rail Vision Ltd Warrant
RVSNW
$1.09M
$127K 0.01%
+226,120
New +$14.1K
ICON
137
Icon Energy
ICON
$4.18M
$126K 0.01%
+298
New +$159K
ZAPPW
138
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
$116K 0.01%
37,500
SES icon
139
SES AI
SES
$205M
$108K 0.01%
+168,459
New +$176K
GRRR
140
Gorilla Technology Group
GRRR
$337M
$74.2K 0.01%
17,339
-1,036,489
-98% -$3.1M
HUBCW icon
141
Hub Cyber Security Warrant 2/27/28
HUBCW
$196K
$61.4K 0.01%
101,139
OABIW icon
142
OmniAb Inc Warrant
OABIW
$50.1K 0.01%
11,833
BJDX icon
143
Bluejay Diagnostics
BJDX
$1.14M
$40.5K ﹤0.01%
1,596
+1,248
+359% +$89.4K
HAO icon
144
Haoxi Health Technology Ltd
HAO
$1.26M
$19.1K ﹤0.01%
+17
New +$200K
SUNE
145
SUNation Energy
SUNE
$9.61M
$17.9K ﹤0.01%
+13
New +$128K
XBPEW
146
XBP Europe Holdings Warrant
XBPEW
$13.4K ﹤0.01%
12,537
EDBLW
147
Edible Garden AG Warrant
EDBLW
$118K
$13.3K ﹤0.01%
50,000
-220,000
-81% -$3.87K
ZCARW
148
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$2.64K ﹤0.01%
18,750
PBMWW
149
Psyence Biomedical Warrant
PBMWW
$454K
$1.25K ﹤0.01%
12,500
BA icon
150
Boeing
BA
$167B
-20,000
Closed -$3.43M

Similar funds

Anson Funds Management's Q3 2024 Portfolio in Review

As of Q3 2024, Anson Funds Management held 220 positions worth $1B, up 19% from $839M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Anson Funds Management deployed $128M of net new capital in Q3 2024, opening 64 new positions and adding to 24 existing holdings. Its largest new stake was FIVE9: 1,476,744 shares worth $42.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was Gildan, an estimated $84.1M trimmed.

  • Anson Funds Management's largest Q3 2024 buy was FIVE9: 1,476,744 shares worth $42.4M.
  • Anson Funds Management added most to Occidental Petroleum in Q3 2024, an estimated $42.5M increase.
  • Anson Funds Management's biggest Q3 2024 reduction was Gildan, cutting an estimated $84.1M.
  • Anson Funds Management fully exited Summit Therapeutics in Q3 2024, selling an estimated $7.35M.
  • Anson Funds Management's ten largest holdings make up 45% of its $1B portfolio in Q3 2024.
  • Anson Funds Management opened 64 new positions and closed 63 in Q3 2024.
  • Anson Funds Management's portfolio value rose 19% quarter-over-quarter to $1B.

Based on Anson Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.